Author Archives: Denise Bell

Co-Diagnostics has obtained regulatory authorization to be sold as an in vitro diagnostic (“IVD”) for the diagnosis of COVID-19 in markets that accept CE markings. The Co-Diagnostics Logix Smart DS test kit detects the presence of certain genes of the COVID-19 virus directly from human saliva samples while eliminating RNA extraction of the samples. Eliminating […]

Turner Imaging Systems has won a small Business Technology Transfer (STTR) Phase I contract from the U.S. Air Force. Turner will use the non-dilutive funds to develop a next generation compact, highly portable, battery-powered full-body fluoroscopic X-ray (Smart-C) to help Special Operations Surgical Teams, Army Forward Surgical Teams (FSTs), and Navy Fleet Surgical Teams, save […]

Tula Health recently raised $24.1 million in debt and equity financing from two venture firms – Springtide Ventures, a health tech venture firm based in Utah and Boston, and Sandbox Capital Advisors based in Salt Lake City. The company creates behavioral change guidance via on-call support, and supporting hardware and software to help their customers […]

The nView s1, nView medical’s breakthrough imaging system, reached its 50th surgery. Twelve surgeons across three leading pediatric hospitals have used nView’s insta-3D™ technology on procedures ranging from spinal deformity corrections, to discectomies, periacetabular osteotomies and extremity procedures. nView medical CEO, Cristian Atria, said, “To celebrate the 50th surgery milestone we gave the nView s1 […]

Following the close of $12M in Series A funding, Xenter, Inc., the world’s first start-up Device-Data-Drug healthcare technologies company, announced the launch of the Xenter Therapeutics business unit. Xenter Therapeutics will lead the therapeutic drug element of Xenter’s mission and vision and is headed by President and Xenter board member David J. Bearss, PhD, a biotech […]

Blackrock Neurotech, the world’s leading platform for brain-computer interface (BCI) technology and manufacturing, has closed a $10 million financing round, led by Christian Angermayer’s re.Mind Capital with participation from Peter Thiel, German entrepreneur Tim Sievers, and Sorenson Impact’s University Venture Fund II. The funding will further expand programs on the Blackrock platform, including clinical studies […]